Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OLMA

Olema Pharmaceuticals Inc

May 29 • 04:00PM ET

13.19

+0.43 3.37 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: IDYA RCUS TNGX CGON KYMR NUVL BMRN RYTM INCY KRYS

| Held by: XBI VTI IWM VXF IWN IBB VTWO DFAS SCHA DFMC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.03	Insider Own	19.14%	Shs Outstand	87.33M	Perf Week	-6.19%
Market Cap	1.15B	Forward P/E	-	EPS next Y	-2.32	Insider Trans	-4.87%	Shs Float	70.63M	Perf Month	-6.72%
Enterprise Value	650.72M	PEG	-	EPS next Q	-0.55	Inst Own	100.17%	Short Float	16.41%	Perf Quarter	-45.50%
Income	-185.15M	P/S	-	EPS this Y	-17.49%	Inst Trans	12.76%	Short Ratio	7.85	Perf Half Y	-49.41%
Sales	0.00M	P/B	2.40	EPS next Y	-5.65%	ROA	-39.38%	Short Interest	11.59M	Perf YTD	-47.24%
Book/sh	5.50	P/C	2.28	EPS next 5Y	0.31%	ROE	-42.86%	52W High	36.26 -63.62%	Perf Year	148.87%
Cash/sh	5.79	P/FCF	-	EPS past 3/5Y	10.68% -25.06%	ROIC	-38.30%	52W Low	3.89 239.07%	Perf 3Y	151.24%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.18% 6.02%	Perf 5Y	-52.83%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-3.83%	Oper. Margin	-	ATR (14)	0.85	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.88	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	39.44	Recom	1.15
Dividend Gr. 3/5Y	- -	Current Ratio	10.88	EPS Q/Q	-45.18%	SMA20	-5.36%	Beta	1.99	Target Price	41.82
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-10.37%	Rel Volume	1.09	Prev Close	12.76
Employees	131	LT Debt/Eq	0.01	Earnings	May 12 BMO	SMA200	-21.16%	Avg Volume	1.48M	Price	13.19
IPO	Nov 19, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.02% -	Trades		Volume	1,606,676	Change	3.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)